3//SEC Filing
OYSTER POINT PHARMA I, LLC 3
Accession 0000899243-19-026381
CIK 0001720725other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 8:02 PM ET
Size
7.4 KB
Accession
0000899243-19-026381
Insider Transaction Report
Form 3
OYSTER POINT PHARMA I, LLC
10% Owner
Holdings
Series B Convertible Preferred Stock
→ Common Stock, par value $0.001 per share (955,392 underlying)
Footnotes (2)
- [F1]These shares of Series B Convertible Preferred Stock will automatically be converted into shares of the Issuer's Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock has no expiration date.
- [F2]Consists of 955,392 shares of common stock beneficially owned by Oyster Point Pharma I, LLC. William J. Link, as a managing partner of Oyster Point Pharma I, LLC, may be deemed to share voting and dispositive power over the shares held by Oyster Point Pharma I, LLC.
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001769046
Filing Metadata
- Form type
- 3
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 8:02 PM ET
- Size
- 7.4 KB